IL155567A0 - Method of diagnosing and treating cartilaginous disorders - Google Patents
Method of diagnosing and treating cartilaginous disordersInfo
- Publication number
- IL155567A0 IL155567A0 IL15556701A IL15556701A IL155567A0 IL 155567 A0 IL155567 A0 IL 155567A0 IL 15556701 A IL15556701 A IL 15556701A IL 15556701 A IL15556701 A IL 15556701A IL 155567 A0 IL155567 A0 IL 155567A0
- Authority
- IL
- Israel
- Prior art keywords
- polypeptides
- present
- diagnosing
- nucleic acid
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25451300P | 2000-12-08 | 2000-12-08 | |
| PCT/US2001/047933 WO2002059308A2 (en) | 2000-12-08 | 2001-12-07 | Method of diagnosing and treating cartilage disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155567A0 true IL155567A0 (en) | 2003-11-23 |
Family
ID=22964573
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15556701A IL155567A0 (en) | 2000-12-08 | 2001-12-07 | Method of diagnosing and treating cartilaginous disorders |
| IL155567A IL155567A (en) | 2000-12-08 | 2003-04-24 | Method of diagnosing and treating cartilaginous disorders |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL155567A IL155567A (en) | 2000-12-08 | 2003-04-24 | Method of diagnosing and treating cartilaginous disorders |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070160594A1 (xx) |
| EP (1) | EP1364023B1 (xx) |
| JP (1) | JP2005501513A (xx) |
| AT (1) | ATE329026T1 (xx) |
| AU (1) | AU2002246633B2 (xx) |
| CA (1) | CA2426102A1 (xx) |
| CY (1) | CY1105204T1 (xx) |
| DE (1) | DE60120500T2 (xx) |
| DK (1) | DK1364023T3 (xx) |
| ES (1) | ES2269509T3 (xx) |
| IL (2) | IL155567A0 (xx) |
| PT (1) | PT1364023E (xx) |
| WO (1) | WO2002059308A2 (xx) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1691820A4 (en) | 2003-11-08 | 2010-03-03 | Prothera Biolog | PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE |
| AU2007261530B2 (en) * | 2006-06-20 | 2014-02-06 | Genzyme Corporation | Serum-free media and their uses for chondrocyte expansion |
| AU2008246125B2 (en) | 2007-04-26 | 2013-01-24 | Genera Istrazivanja D.O.O. | Blood biomarkers for bone fracture and cartilage injury |
| DK2291654T3 (en) | 2008-05-28 | 2018-06-14 | Prothera Biologics Inc | PREPARATION AND COMPOSITION OF BLOOD INTER-ALPHA INHIBITOR PROTEINS |
| WO2010038610A1 (ja) * | 2008-09-30 | 2010-04-08 | オリエンタル酵母工業株式会社 | 新しい軟骨細胞増殖及び分化誘導剤 |
| WO2010068308A1 (en) * | 2008-12-10 | 2010-06-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease |
| CN101954071B (zh) * | 2010-10-08 | 2013-09-25 | 广东天普生化医药股份有限公司 | 乌司他丁作为制备治疗系统性红斑狼疮药物的用途及其药物组合物 |
| CN101972471B (zh) * | 2010-10-08 | 2013-09-25 | 广东天普生化医药股份有限公司 | 乌司他丁用于制备治疗自身免疫性脑脊髓炎药物的用途及其药物组合物 |
| EP3598977B1 (en) | 2011-06-03 | 2024-02-14 | MaGuire Abbey, LLC | Method, composition, and articles for improving joint lubrication |
| CA2885604A1 (en) | 2012-09-09 | 2014-03-13 | Prothera Biologics, Inc. | Treatment of ischemia using inter-alpha inhibitor proteins |
| US9944895B2 (en) | 2013-03-28 | 2018-04-17 | Ge Healthcare Bio-Sciences Ab | Method for cell culture |
| US10125349B2 (en) | 2013-03-28 | 2018-11-13 | Ge Healthcare Bio-Sciences Ab | Method for cell culture |
| CN105816862A (zh) * | 2016-03-17 | 2016-08-03 | 广东天普生化医药股份有限公司 | 乌司他丁在制备治疗前列腺癌药物中的用途 |
| CN105770874A (zh) * | 2016-03-17 | 2016-07-20 | 广东天普生化医药股份有限公司 | 乌司他丁在制备治疗多发性硬化药物中的用途 |
| CN105770875A (zh) * | 2016-03-17 | 2016-07-20 | 广东天普生化医药股份有限公司 | 乌司他丁在制备治疗食管癌药物中的用途 |
| CN105770877A (zh) * | 2016-05-30 | 2016-07-20 | 广东天普生化医药股份有限公司 | 乌司他丁在制备治疗膀胱癌药物中的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5444047A (en) * | 1994-06-16 | 1995-08-22 | Dipasquale; Gene | Treatment of arthritic and post-surgical orthopedic conditions with Insulin-like Growth Factor-I |
-
2001
- 2001-12-07 DE DE60120500T patent/DE60120500T2/de not_active Expired - Fee Related
- 2001-12-07 AU AU2002246633A patent/AU2002246633B2/en not_active Ceased
- 2001-12-07 CA CA002426102A patent/CA2426102A1/en not_active Abandoned
- 2001-12-07 ES ES01994210T patent/ES2269509T3/es not_active Expired - Lifetime
- 2001-12-07 JP JP2002559793A patent/JP2005501513A/ja not_active Withdrawn
- 2001-12-07 EP EP01994210A patent/EP1364023B1/en not_active Expired - Lifetime
- 2001-12-07 PT PT01994210T patent/PT1364023E/pt unknown
- 2001-12-07 DK DK01994210T patent/DK1364023T3/da active
- 2001-12-07 WO PCT/US2001/047933 patent/WO2002059308A2/en active IP Right Grant
- 2001-12-07 IL IL15556701A patent/IL155567A0/xx unknown
- 2001-12-07 AT AT01994210T patent/ATE329026T1/de not_active IP Right Cessation
-
2003
- 2003-04-24 IL IL155567A patent/IL155567A/en not_active IP Right Cessation
-
2006
- 2006-08-24 CY CY20061101188T patent/CY1105204T1/el unknown
- 2006-12-18 US US11/612,263 patent/US20070160594A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60120500T2 (de) | 2007-06-06 |
| IL155567A (en) | 2008-12-29 |
| WO2002059308A2 (en) | 2002-08-01 |
| EP1364023A2 (en) | 2003-11-26 |
| US20070160594A1 (en) | 2007-07-12 |
| DK1364023T3 (da) | 2006-10-09 |
| ATE329026T1 (de) | 2006-06-15 |
| WO2002059308A3 (en) | 2003-09-18 |
| CA2426102A1 (en) | 2002-08-01 |
| EP1364023B1 (en) | 2006-06-07 |
| ES2269509T3 (es) | 2007-04-01 |
| CY1105204T1 (el) | 2010-03-03 |
| PT1364023E (pt) | 2006-10-31 |
| JP2005501513A (ja) | 2005-01-20 |
| DE60120500D1 (de) | 2006-07-20 |
| AU2002246633B2 (en) | 2007-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL155567A0 (en) | Method of diagnosing and treating cartilaginous disorders | |
| CY1106885T1 (el) | Θεραπευτικες χρησεις il-17-ομολογων πολυπεπτιδιων | |
| DE60228997D1 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung eines tumors | |
| ATE447583T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
| CY1112334T1 (el) | Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων | |
| MXPA01002592A (es) | Polipeptidos de transmembrana y secretados y acidos nucleicos que codifican los mismos. | |
| KR100468977B1 (ko) | 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산 | |
| DK1386931T3 (da) | Human neurotriminhomolog | |
| WO2002016611A3 (en) | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders | |
| WO2003076569A3 (en) | Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same | |
| KR100515858B1 (en) | PRO617 Polypeptides | |
| WO2002101069A3 (en) | Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders | |
| KR100515857B1 (en) | PRO792 Polypeptides | |
| KR100515856B1 (en) | PRO618 Polypeptides | |
| KR100515855B1 (en) | PRO351 Polypeptides | |
| DE60038986D1 (de) | Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure | |
| DK1241184T3 (da) | Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette | |
| PT1241183E (pt) | Proteína semelhante a hcar humana e ácidos nucleicos que a codificam | |
| DE69943058D1 (de) | Loslösendes protein 5 - ucp5 | |
| DK1191101T3 (da) | PRO241 polypeptider og nucleinsyre kodende herfor |